​

Eledon Pharmaceuticals (ELDN) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

ELDN Stock Forecast

Eledon Pharmaceuticals (ELDN) stock forecast, based on 4 Wall Street analysts, predicts a 12-month average price target of $5.00, with a high of $5.00 and a low of $5.00. This represents a 62.87% increase from the last price of $3.07.

High: $5 Avg: $5 Low: $5 Last Closed Price: $3.07

ELDN Stock Rating

Eledon Pharmaceuticals stock's rating consensus is Buy, based on 4 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 4 Buy (100.00%), 0 Hold (0.00%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 4 0 4 Strong Sell Sell Hold Buy Strong Buy

ELDN Price Target Upside V Benchmarks

TypeNameUpside
StockEledon Pharmaceuticals62.87%
SectorHealthcare Stocks 15.45%
IndustryBiotech Stocks 41.48%

Price Target Trends

1M3M12M
# Anlaysts112
Avg Price Target$5.00$5.00$7.00
Last Closing Price$3.07$3.07$3.07
Upside/Downside62.87%62.87%128.01%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Apr, 26-7---7
Mar, 26-7---7
Feb, 26-7---7
Jan, 26-7---7
Dec, 25-7---7
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Mar 16, 2026Thomas SmithLeerink Partners$5.00$2.7482.48%62.87%
Jun 18, 2025Yi ChenH.C. Wainwright$9.00$2.78223.74%193.16%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Mar 16, 2026Leerink PartnersOutperformOutperformhold
May 07, 2024H.C. WainwrightBuyBuyhold

Financial Forecast

EPS Forecast

$-30 $-24 $-18 $-12 $-6 $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported-$-0.75$-28.73---
Avg Forecast$-1.70$-0.71$-1.08$-1.09$-1.04$-0.92
High Forecast$-1.65$-0.29$-0.81$-0.94$-1.01$-0.92
Low Forecast$-1.79$-1.51$-1.37$-1.24$-1.07$-0.92
Surprise %-5.63%2560.19%---

Revenue Forecast

$15M $22M $29M $36M $43M $50M Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported------
Avg Forecast--$50.00M--$17.40M
High Forecast--$50.00M--$17.40M
Low Forecast--$50.00M--$17.40M
Surprise %------

Net Income Forecast

$-150M $-120M $-90M $-60M $-30M $0 Dec 23 Dec 24 Dec 25 Dec 26 Dec 27 Dec 28
Dec 23Dec 24Dec 25Dec 26Dec 27Dec 28
Reported$-116.54M$-36.18M$-45.62M---
Avg Forecast$-42.40M$-24.55M$-26.79M$-26.83M$-25.60M$-22.65M
High Forecast$-40.64M$-7.18M$-19.96M$-23.04M$-24.84M$-22.65M
Low Forecast$-44.16M$-37.28M$-33.62M$-30.63M$-26.36M$-22.65M
Surprise %174.86%47.40%70.28%---

ELDN Forecast FAQ

Is Eledon Pharmaceuticals stock a buy?

Eledon Pharmaceuticals stock has a consensus rating of Buy, based on 4 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 4 Buy, 0 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that Eledon Pharmaceuticals is a favorable investment for most analysts.

What is Eledon Pharmaceuticals's price target?

Eledon Pharmaceuticals's price target, set by 4 Wall Street analysts, averages $5 over the next 12 months. The price target range spans from $5 at the low end to $5 at the high end, suggesting a potential 62.87% change from the previous closing price of $3.07.

How does Eledon Pharmaceuticals stock forecast compare to its benchmarks?

Eledon Pharmaceuticals's stock forecast shows a 62.87% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the biotech stocks industry (41.48%).

What is the breakdown of analyst ratings for Eledon Pharmaceuticals over the past three months?

  • April 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • March 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.
  • February 2026: 0% Strong Buy, 100.00% Buy, 0% Hold, 0% Sell, 0% Strong Sell.

What is Eledon Pharmaceuticals’s EPS forecast?

Eledon Pharmaceuticals's average annual EPS forecast for its fiscal year ending in December 2026 is $-1.09, marking a -96.21% decrease from the reported $-28.73 in 2025. Estimates for the following years are $-1.04 in 2027, and $-0.92 in 2028.

What is Eledon Pharmaceuticals’s revenue forecast?

Eledon Pharmaceuticals's average annual revenue forecast for its fiscal year ending in December 2026 is $0, reflecting a 0% decrease from the reported $0 in 2025. The forecast for 2027 is $0, and $17.4M for 2028.

What is Eledon Pharmaceuticals’s net income forecast?

Eledon Pharmaceuticals's net income forecast for the fiscal year ending in December 2026 stands at $-26.835M, representing a -41.17% decrease from the reported $-45.617M in 2025. Projections indicate $-25.604M in 2027, and $-22.65M in 2028.